Our patent portfolio is comprised of over 69 patents and applications licensed exclusively from Harvard for all fields of use outside drug development.  This IP enables and protects our core competencies. Over time, the company will have access to newly developed IP and expertise from the laboratories of Professor George Whitesides, our scientific Founder, and of our broad network of university collaborators.  In addition, we have generated over two dozen additional patent applications to date to further protect and expand our portfolio and to protect our partners’ commercial interests.